Use of 68Ga-PSMA PET/CT to Stratify Patients With PI-RADS 3 Lesions According to Clinically Significant Prostate Cancer Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Prostate
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The use of 68 Ga-PSMA PET/CT to stratify patients with PI-RADS 3 lesions according to clinically significant prostate cancer risk
Prostate 2022 Dec 21;[EPub Ahead of Print], J Yang, Y Tang, C Zhou, M Zhou, J Li, S HuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.